Reviewed,
UniProtKB/Swiss-Prot P00608 (PA22_NOTSC)
Last modified
June 16, 2009.
Version 82.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Phospholipase A2 EC=3.1.1.4 Alternative name(s): Notexin Phosphatidylcholine 2-acylhydrolase |
| Organism | Notechis scutatus scutatus (Mainland tiger snake) (Common tiger snake) |
| Taxonomic identifier | 70142 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Lepidosauria › Squamata › Scleroglossa › Serpentes › Colubroidea › Elapidae › Acanthophiinae › Notechis |
Protein attributes
| Sequence length | 119 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. Acts presynaptically. Is directly toxic to skeletal muscle upon local application in vivo (dystrophic effect). |
| Catalytic activity | Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. |
| Cofactor | Binds 1 calcium ion per subunit. |
| Subunit structure | Monomer. |
| Subcellular location | |
| Tissue specificity | Expressed by the venom gland. |
| Toxic dose | LD50 is 0.025 mg/kg by intravenous injection. |
| Miscellaneous | Activity and lethal neurotoxicity are lost upon modification with p-bromophenacyl bromide. |
| Sequence similarities | Belongs to the phospholipase A2 family. Group I subfamily. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Lipid degradation |
| Cellular component | Secreted |
| Ligand | Calcium Metal-binding |
| Molecular function | Hydrolase Neurotoxin Presynaptic neurotoxin Toxin |
| PTM | Disulfide bond |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | lipid catabolic process Inferred from electronic annotation. Source: UniProtKB-KW pathogenesisInferred from electronic annotation. Source: UniProtKB-KW phospholipid metabolic processInferred from electronic annotation. Source: InterPro synaptic transmissionInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell presynaptic membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | calcium ion binding Inferred from electronic annotation. Source: UniProtKB-KW phospholipase A2 activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 119 | 119 | Phospholipase A2 | PRO_0000161675 | ||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||
| Active site | 48 | 1 | Ref.3 Ref.5 | |||||||||||||||||||||||||||
| Active site | 93 | 1 | Ref.3 | |||||||||||||||||||||||||||
| Metal binding | 28 | 1 | Calcium; via carbonyl oxygen | |||||||||||||||||||||||||||
| Metal binding | 30 | 1 | Calcium; via carbonyl oxygen | |||||||||||||||||||||||||||
| Metal binding | 32 | 1 | Calcium; via carbonyl oxygen | |||||||||||||||||||||||||||
| Metal binding | 49 | 1 | Calcium | |||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||
| Disulfide bond | 11 ↔ 71 | |||||||||||||||||||||||||||||
| Disulfide bond | 27 ↔ 118 | |||||||||||||||||||||||||||||
| Disulfide bond | 29 ↔ 45 | |||||||||||||||||||||||||||||
| Disulfide bond | 44 ↔ 99 | |||||||||||||||||||||||||||||
| Disulfide bond | 51 ↔ 92 | |||||||||||||||||||||||||||||
| Disulfide bond | 60 ↔ 85 | |||||||||||||||||||||||||||||
| Disulfide bond | 78 ↔ 90 | |||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||
| Natural variant | 16 | 1 | K → R in variant S. | |||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||
| Helix | 2 – 12 | 11 | ||||||||||||||||||||||||||||
| Turn | 13 – 15 | 3 | ||||||||||||||||||||||||||||
| Helix | 19 – 22 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 23 – 25 | 3 | ||||||||||||||||||||||||||||
| Turn | 26 – 28 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 29 – 31 | 3 | ||||||||||||||||||||||||||||
| Helix | 40 – 57 | 18 | ||||||||||||||||||||||||||||
| Beta strand | 69 – 72 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 75 – 78 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 81 – 83 | 3 | ||||||||||||||||||||||||||||
| Helix | 84 – 102 | 19 | ||||||||||||||||||||||||||||
| Helix | 107 – 109 | 3 | ||||||||||||||||||||||||||||
| Helix | 114 – 117 | 4 | ||||||||||||||||||||||||||||
Sequences
References
| [1] | "Amino acid sequence of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake)." Halpert J., Eaker D. J. Biol. Chem. 250:6990-6997(1975) [PubMed: 1158892] [Abstract] Cited for: PROTEIN SEQUENCE. Tissue: Venom. |
| [2] | "On the purification of notexin. Isolation of a single amino acid variant from the venom of Notechis scutatus scutatus." Chwetzoff S., Mollier P., Bouet F., Rowan E.G., Harvey A.L., Menez A. FEBS Lett. 261:226-230(1990) [PubMed: 2155818] [Abstract] Cited for: PROTEIN SEQUENCE (NOTEXIN-S). Tissue: Venom. |
| [3] | "The role of phospholipase activity in the action of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake)." Halpert J., Eaker D., Karlsson E. FEBS Lett. 61:72-76(1976) [PubMed: 1245225] [Abstract] Cited for: ACTIVE SITE. |
| [4] | "Tryptophan 110, a residue involved in the toxic activity but not in the enzymatic activity of notexin." Mollier P., Chwetzoff S., Bouet F., Harvey A.L., Menez A. Eur. J. Biochem. 185:263-270(1989) [PubMed: 2583182] [Abstract] Cited for: INVOLVEMENT OF TRP-110 IN TOXICITY. |
| [5] | "The three-dimensional structure of notexin, a presynaptic neurotoxic phospholipase A2 at 2.0-A resolution." Westerlund B., Nordlund P., Uhlim U., Eaker D., Eklund H. FEBS Lett. 301:159-164(1992) [PubMed: 1568473] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS). |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIR | PSNOAT. A00749. PSNOAS. S08258. | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P00608. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 3.1.1.4. 292759. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR016090. Phospholipase_A2. IPR013090. Phospholipase_A2_AS. IPR001211. Phospholipase_A2_euk. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:1.20.90.10. Phospholipase_A2. 1 hit. | ||||||||||||
| PANTHER | PTHR11716. Phospholipase_A2. 1 hit. | ||||||||||||
| Pfam | PF00068. Phospholip_A2_1. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00389. PHPHLIPASEA2. | ||||||||||||
| ProDom | PD000303. PhospholipaseA2. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00085. PA2c. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00119. PA2_ASP. 1 hit. PS00118. PA2_HIS. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Entry information
| Entry name | PA22_NOTSC | ||||||||
| Accession | Primary (citable) accession number: P00608 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


